/

/

Master Trial Index (All Years)

/

Verma et al.

Category

GI / Nutrition / Metabolic

Full Summary

https://app.notion.com/p/3ab1a8cd5af18139b756fc03b7b9ce5a

Journal

Am J Gastroenterol

Takeaway

Empirical antifungal therapy substantially improved survival in high-IFI-risk ACLF (35% vs 13%).

Verdict

Positive

Year

2025

myICUnotes © 2026 by Dr Abhijeet Anand is licensed under CC BY-NC-SA 4.0. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-sa/4.0/